Bio logo

Leonardo Royal Hotel London St Paul's

28 February 2024

Pharma Sustainability Integrates 2024

Leonardo Royal Hotel London St Paul's, 28 February 2024


Focused on pharma leaders and policy makers


Gold Sponsors

Silver Sponsors

Bronze Sponsors



How are the sustainability policies and expectations of government, investors, and customers shaping the future of pharma.


How can innovative technology help to reduce the carbon footprint of the entire pharmaceutical supply chain, from manufacturing to patient delivery?

08:30 – 09:30

Registration and Networking

09:30 – 09:40

Welcome & Opening Remarks:

Roz Bekker

Managing Director, Janssen UK & Ireland
ABPI Board Sponsor, Sustainability

Introduced by:

Richard Torbett
Chief Executive Officer, ABPI

09:40 – 09:55

Keynote Address: ‘Homeopathy for Heat’

Hugh Montgomery OBE

Professor Intensive Care Medicine, UCL & Co-founder, Real Zero

10:00 – 10:30

Fireside Chat:
‘Adoption of new technologies and digital solutions to reduce the carbon footprint of Pharma supply chains’

Speakers include:

Giuseppe Whelan
Medicine Development & Industrialisation, Sustainability Head, GSK

Matt Shaughnessy
Head of Operations Sustainability, AstraZeneca

Duncan Flack
Global Sustainability Lead, Honeywell & Chairman, CiPPPA

Interviewed by:

Dave Tudor
Managing Director, Medicines Manufacturing Innovation Centre,
Biologics & Quality, CPI

Session 1

10:35 – 11.25

Measuring up: how do we measure environmental impact?

In creating the greener operating framework of the future: how do we measure environmental impact and use these measures to drive change?

Facilitated by:

Fiona Adshead

Chair, Sustainable Healthcare Coalition

Panellists Include:

Niels Lund
Vice President, Climate Change & Health, Novo Nordisk

Richard Henderson
Sustainability Leader, GSK

Alex Wilkinson
Respiratory Consultant & Clinical Lead for Respiratory Infection and TB, East and North Hertfordshire NHS Trust

Michael Clarke
Partnerships Director, British Generic Manufacturers Association (BGMA)

Neil MacKillop
Executive Director, AstraZeneca

11:25 – 11.55

Networking coffee break

Session 2

11:55 – 12:45

Supply Chain Gains

Collaboration between pharma development, manufacturing and supply is essential for a more efficient and more sustainable pharma supply chain. How can technological advances facilitate a more connected and less wasteful supply chain?

Facilitated by:

Laura Kelly

Partner – ESG Reporting and Assurance, PwC UK

Panellists Include:

Matt Shaughnessy
Head of Operations Sustainability, AstraZeneca

Richard Dunn
VP Business Development & Account Management, Life Sciences & Healthcare, DHL Supply Chain

Laura Griffiths
Innovation Lead, Medicines Manufacturing, Innovate UK, UKRI

Joris De Keijser
Head of Strategy, Ajinomoto Bio-Pharma Services

12.45 – 13.45

Networking lunch break

Session 3

13.45 – 14.35

Greenification of careers in the industry

As the urgency to address climate change grows, choosing a role aligned with sustainability is becoming a top priority but many ask the question ‘what can I do to make a difference?’

Embracing green careers is crucial in the face of climate change. In the life sciences industry, professionals are actively contributing to sustainability. From investing in renewable energy to creating low-carbon inhalers and achieving net zero buildings, the industry is making a significant impact. The ‘greenification’ of existing roles is a key factor in attracting talent, shaping industry perception, and ensuring the necessary upskilling for retention and achieving net zero goals.

Facilitated by:

Andrew Croydon

Director, Education and Examination Policy & Partnerships, The ABPI

Panellists Include:

Chris Blackburn
Head of Corporate Social Responsibility, Impellam Group

Aalia Kazi
Corporate Responsibility and Sustainability Partner, Roche

Peter Collins
Director, Global Health and Social Impact, Pfizer

Perdita Cresser
Shared Value and Sustainability Manager, Chiesi

Session 4

14.40 – 15.30

COP or Cop-out?

The recent COP28 conference highlighted the urgency and pace needed to reach Net Zero goals. How can the healthcare, pharma, and wider life sciences sectors build on the outcomes of COP28?

Facilitated by:

John Arthur

Director, Medicines Manufacturing Innovation Centre, CPI

Panellists Include:

Ryan Robinson
Founder and CEO, Aeropowder

Rob Holdway
Managing Director, Giraffe Innovation

Dave Ennis
VP Environmental Protection, Operations, Global Sustainability & SHE, AstraZeneca

Harriet Lewis
Director Market Access & Public Affairs
Chiesi UK

15.30 – 16.30

Networking drinks reception

Gold Sponsors

Silver Sponsors

Bronze Sponsors

Sign up for life science integrates news

Get the latest news and updates by signing up today.

By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.